Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.
Burzynski SR, Janicki TJ, Weaver RA, Burzynski B. Burzynski SR, et al. Among authors: burzynski b. Integr Cancer Ther. 2006 Mar;5(1):40-7. doi: 10.1177/1534735405285380. Integr Cancer Ther. 2006. PMID: 16484713 Free article. Clinical Trial.
Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.
Burzynski SR, Kubove E, Burzynski B. Burzynski SR, et al. Among authors: burzynski b. Drugs Exp Clin Res. 1990;16(7):361-9. Drugs Exp Clin Res. 1990. PMID: 2152694 Clinical Trial.
Toxicology studies on antineoplaston AS2-1 injections in cancer patients.
Burzynski SR, Burzynski B, Mohabbat MO. Burzynski SR, et al. Among authors: burzynski b. Drugs Exp Clin Res. 1986;12 Suppl 1:25-35. Drugs Exp Clin Res. 1986. PMID: 3743378
Chemo-surveillance: a novel concept of the natural defence mechanism against cancer.
Liau MC, Szopa M, Burzynski B, Burzynski SR. Liau MC, et al. Among authors: burzynski b. Drugs Exp Clin Res. 1987;13 Suppl 1:71-6. Drugs Exp Clin Res. 1987. PMID: 3569019
Quantitative assay of plasma and urinary peptides as an aid for the evaluation of cancer patients undergoing antineoplaston therapy.
Liau MC, Szopa M, Burzynski B, Burzynski SR. Liau MC, et al. Among authors: burzynski b, burzynski sr. Drugs Exp Clin Res. 1987;13 Suppl 1:61-70. Drugs Exp Clin Res. 1987. PMID: 3569018
Chemoprevention by antineoplaston A10 of benzo(a)pyrene-induced pulmonary neoplasia.
Kampalath BN, Liau MC, Burzynski B, Burzynski SR. Kampalath BN, et al. Among authors: burzynski b, burzynski sr. Drugs Exp Clin Res. 1987;13 Suppl 1:51-5. Drugs Exp Clin Res. 1987. PMID: 3569016
Phase I clinical studies of antineoplaston A5 injections.
Burzynski SR, Kubove E, Burzynski B. Burzynski SR, et al. Among authors: burzynski b. Drugs Exp Clin Res. 1987;13 Suppl 1:37-43. Drugs Exp Clin Res. 1987. PMID: 3569014
Prediction of detrusor underactivity based on non-invasive functional tests and clinical data in patients with symptoms of bladder outlet obstruction.
Szmydki D, Burzyński B, Sołtysiak-Gibała Z, Przymuszała P, Trzewik M, Chudek J, Owczarek AJ. Szmydki D, et al. Among authors: burzynski b. Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):10992-10998. doi: 10.26355/eurrev_202011_23583. Eur Rev Med Pharmacol Sci. 2020. PMID: 33215413 Free article.
Neutrophil-to-mean platelet volume ratio as a new predictor for overall and cancer-specific survival in patients with localized clear cell renal cell carcinoma.
Życzkowski M, Rajwa P, Burzyński B, Gaździk M, Florczyk I, Slabon-Turska M, Paradysz A. Życzkowski M, et al. Among authors: burzynski b. Arch Med Sci. 2019 Mar 25;16(5):1072-1077. doi: 10.5114/aoms.2019.83822. eCollection 2020. Arch Med Sci. 2019. PMID: 32863996 Free PMC article.
Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre study.
Först G, de With K, Weber N, Borde J, Querbach C, Kleideiter J, Seifert C, Hagel S, Ambrosch A, Löbermann M, Schröder P, Steib-Bauert M, Kern WV; ABS-QI Study Group. Först G, et al. J Antimicrob Chemother. 2017 Oct 1;72(10):2931-2937. doi: 10.1093/jac/dkx244. J Antimicrob Chemother. 2017. PMID: 29091214
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback